glp-1 agonist dopamine GLP-1s Like Ozempic May Be a New Treatment for Addiction Possible mechanisms by which GLP-1

Lancet 14:110 Son JW, Kim S (2020) Comprehensive review of current and upcoming anti-obesity drugs

The observed protective effects are mediated through multiple molecular mechanisms, including enhanced metabolic regulation, direct anti-proliferative actions, and augmented immune surveillance [16, 17]

Dual-acting oral GLP-1s are not yet available, but they are expected in the future

A novel glucagon-like peptide-1 (GLP-1)/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed mice The study examines the effectiveness of novel peptides that are a combination of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon